Small Cap Feast

Small Cap Feast – 26 September 2019

Dish of the Day:

VAALCO Energy (EGY). (NYSE: EGY),  – an independent energy company focused on development and production assets in West Africa, announces the dual listing on the Standard Listing on the Main Market of London Stock Exchange, to complement its existing Listing on the New York Stock Exchange.

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market Standard, the largest Payments, Marketplace and Fintech Ecosystem in Kazakhstan with a leading market share in each of its key products and services. GDR offering expected Oct 2019.  In the first half of 2019, the Company generated total revenue of KZT226,862m (U.S. $598m), up 34% and net income of KZT77,001m (U.S. $203m), up 54%

Main Market premium

Registration document approved for Helios Towers. The Group provides essential network services, flexible infrastructure solutions and reliable power supply to mobile network operators  in five African growth economies.  Revenue increased 7 per cent. year-on-year to US$191m (H1 2018: US$178m), with Adjusted EBITDA up 15 per cent. year-on-year at US$99m (H1 2018: US$86m) for the six months ended 30 June 2019.

Breakfast Buffet

Xeros Tech Grp (XSG) 7.11p £18.28m

Xeros Technology Group, the developer and provider of water saving and filtration technologies with multiple commercial applications, has spun out its Qualus tanning business operations to its management team in exchange for an exclusive worldwide licensing and royalty agreement.

The Qualus management team has formed a new company, ESTR Limited, which has acquired the physical assets associated with the business, its contracts including the LEFARC agreement and the brand “Qualus”.

Xeros has provided ESTR with a capped convertible loan facility in order to fund the business until the end of December 2019. The management team plan to raise further financing to fully commercialise the business.

ESTR has the exclusive rights for the use of Xeros’ patents in the tanning market and will pay the Group a royalty on its worldwide income in respect of these patents.

This spin-out will reduce the Group’s cost base beyond December 2019 as part of the previously communicated intention to be a pure play licensing company with a monthly cash burn rate of £0.6m per month from January 2020.

Trakm8 Holdings (TRAK) 20p £9.75m

Trakm8 Holdings the global telematics and data insight provider, is today announces the following trading update.

Half Year revenues are expected to be modestly ahead of last year, direct and indirect costs significantly lower. The Half Year adjusted loss therefore should be considerably lower than last year. 

Net debt excluding leases at the end of the Half Year will be in the range £5.6m to £5.8m (31.3.19: £5.6m), which is a very significant improvement on the cash outflow of the corresponding period of the previous year.  Even if the R&D tax reclaim is not received until October, the cash outflow will be significantly reduced on the corresponding period of the previous year.

The second half of the year will benefit from commencement of shipments to new volume insurance customers, resumption of shipments to our automotive customers along with the improved sales performance in the Fleet market. Direct and indirect costs are expected to continue to reduce, delivering incremental savings over and above the £2m communicated last financial year.

Creo Medical Group (CREO) 148p £179m

Creo Medical Group, a medical device company focused on the emerging field of surgical endoscopy, announces it has entered into a Distribution Partner Framework Agreement with MEDITEK SYSTEMS, to provide clinical training and market seeding across the Indian market for Creo’s CROMA Advance Energy platform and suite of products, including the Speedboat device, ahead of their official launch. 

Meditek will collaborate with Creo to advance the roll out of Creo’s Clinical Education Programme across the Indian market, training key clinicians in the use of Speedboat and the CROMA platform with the aim of ensuring quality control and best patient outcomes. Creo’s Clinical Education Programme ensures that distributor trainers, having been carefully mentored, can then deliver in-country training for clinicians at a consistently high standard.

In addition, doctors and nurses from six key healthcare institutions in India have already completed training as part of Creo’s Clinical Education Programme ahead of the mentoring phase of the programme with initial cases taking place in India over the coming weeks.

Bidstack Group (BIDS) 26p £63.6m

Bidstack Group, the in-game advertising group, announced it has extended its multi-year partnership with Sports Interactive, Sega’s world leading developer of football management simulations, by a further three years giving Bidstack exclusive rights to serve native in-game ads to the advertising inventory within Football Manager.

The extension follows the success of serving relevant native in-game ads in Sports Interactive’s Football Manager 2018 and Football Manager 2019 titles in a non-intrusive, fully immersive way that does not break the gamer’s experience.

Football Manager 2020 will release in November 2019 for PC, Mac and as a launch title on Google Stadia.

This is the first time Bidstack’s SDK will be running live on any title. The SDK’s functionality will span from added brand safety and security measures, (enhanced by the integration of Pubguard’s ad verification software), to game publishers tracking the real-time health of their inventory in game, via Bidstack’s AdConsole.

Verditek (VDTK) 4p £7m

Verditek announced that it has secured a further material  order with a Nigerian distributor comprising a multi-year take or pay contract that begins with a minimum of 1 MW in the first year and increases to 3 MW in the second year. The first 200 kW will be shipped within 16 weeks and complements the previously announced distribution agreement. Further orders are under negotiation and the directors are confident the pipeline will deliver new commitments in the near future.

The company has ambitious plans to expand and enhance the performance of the plant to bring our product competitively to market and has identified opportunities to increase production capacity cost effectively, as our pipeline continues to grow.

Beeks Fin Cloud (BKS) 86.5p £44m

Beeks Financial Cloud Group, a leading cloud computing and connectivity provider for financial markets, announced the launch of a Bare Metal Automated Backup Service, initially available within its London locations and subsequently in its other locations. This is an automated server image backup for Dedicated Servers and storage within Dedicated Servers, providing backup images of customers’ data in Beeks’ offsite location, via a secure dedicated backup network.

Beeks has launched the service in response to the growing compliance and regulatory pressures for backup and storage being experience by its customers. The service will be provided under a ‘pay-as-you-store’ model, providing another recurring revenue stream for the Group. The service is being launched following a successful proof of concept testing with a small customer set, who are now live on the service.

Location Sciences (LSAI) 2.35p £9.61m

Location Sciences, the leading location data verification and analytics company, announces its unaudited interim results for the six months ended 30 June 2019.


Revenue of £454,872 (2018: £234,307), a 94% increase

Sales run rate per month currently in excess of £100,000

Published “The State of Location Advertising” report demonstrating the need for transparency within the industry and the market opportunity for Verify

Delivered 550m verified impressions versus H1 target of 250m (H1 2018: Nil)

Secured 49 new brands for its Verify platform versus 2019’s target of 50 new brands

Warehouse REIT PLC (WHR) 103p £247.5m

Warehouse REIT, the AIM-listed specialist warehouse investor, announces the exchange of contracts to acquire the Midpoint Estate, a multi-let estate of 20 high quality, individual warehouse units on 29 acres in a strategic location off the M6 motorway in Middlewich, Cheshire for £15.5m, reflecting a net initial yield of 6.6 per cent.

The Midpoint Estate totals 182,500 sq ft with its 20 individual units ranging in size from 2,300 sq ft to 31,600 sq ft, located within two miles of Junction 18 of the M6 motorway and approximately twenty-six miles south of Manchester. The estate comprises high quality, predominantly detached, low density warehouse units, all of which are income producing, and is strategically located in a region with very limited supply of existing and new build alternatives.

Cabot Energy PLC (CAB) 3.75p £1.72m

Cabot Energy, the AIM quoted oil and gas company focussed on creating predictable production growth in Canada, announces that Cabot and Shell Italia E&P S.p.A., have agreed to withdraw from the Cascina Alberto onshore exploration licence in The Po Valley, Northern Italy. Shell will make a payment to the Group to cover the costs and inconveniences incurred in the process of the Withdrawal. The Withdrawal is subject to the approval of the Italian authorities, which is expected during Q4 2019.

GYG (GYG) 41.5p £23m

GYG, the market leading superyacht painting, supply and maintenance company, announced that it has signed contracts for two New Build projects in Northern Europe. These orders come from an existing shipyard partner and the yachts are 60+ meters and 70+ meters respectively. Both vessels are currently under construction and the Group is scheduled to start work on both projects in H1 2020.

Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.